Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,847
Total Claims
$1.1M
Drug Cost
938
Beneficiaries
$1,204
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-50%
Opioid rate vs peers
1.1% vs 2.2% avg
-15%
Cost per patient vs peers
$1,204 vs $1,411 avg
Opioid Prescribing
1.1%
Opioid Rate
155
Opioid Claims
$10K
Opioid Cost
9.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,460 claims · $896K
Generic: 12,246 claims · $223K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 218 | $177K |
| Semaglutide | 72 | $123K |
| Dulaglutide | 47 | $54K |
| Rivaroxaban | 51 | $52K |
| Liraglutide | 13 | $41K |
| Insulin Aspart | 41 | $37K |
| Budesonide/Formoterol Fumarate | 55 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 50 | $30K |
| Insulin Degludec | 27 | $28K |
| Insulin Lispro | 29 | $25K |
| Sitagliptin Phosphate | 30 | $20K |
| Semaglutide | 17 | $20K |
| Empagliflozin | 15 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $16K |
| Tirzepatide | 11 | $12K |
Prescribing Profile
Patient Profile
77
Avg Age
74%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About